J.M. Scherrmann
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Neurology top 5%
- Barrier Structure and Function Studies
Papers in
-
- Receptor Mechanisms and Signaling 4
-
- Poisoning and overdose treatments 6
- Co-authors
- A. Sabouraud (8 shared papers)C Bismuth (6 shared papers)Anthony Régina (2 shared papers)M Debray (6 shared papers)Frédéric J. Baud (7 shared papers)Myriam Rochdi (3 shared papers)Nicolas Perrière (2 shared papers)Mária A. Deli (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Toxicology (3 papers)Clinical Chemistry (2 papers)European Journal of Clinical Pharmacology (2 papers)Journal of Neurochemistry (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
J.M. Scherrmann
50 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Nephrology 168
- Neurology 174
- Pharmacology 126
- Oncology 357
- Emergency Medicine 88
Countries citing papers authored by J.M. Scherrmann
This map shows the geographic impact of J.M. Scherrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Scherrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Scherrmann more than expected).
Fields of papers citing papers by J.M. Scherrmann
This network shows the impact of papers produced by J.M. Scherrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Scherrmann. The network helps show where J.M. Scherrmann may publish in the future.
Co-authors
The 25 scholars most cited alongside J.M. Scherrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 266 | |
| 2 | 2000 | 133 | |
| 3 | 1990 | 105 | |
| 4 | 1994 | 102 | |
| 5 | 1996 | 88 | |
| 6 | 1992 | 63 | |
| 7 | 1987 | 55 | |
| 8 | 2004 | 53 | |
| 9 | 1996 | 37 | |
| 10 | 2003 | 34 | |
| 11 | 1980 | 33 | |
| 12 | 1991 | 31 | |
| 13 | 1994 | 31 | |
| 14 | Binding of colchicine and thiocolchicoside to human serum proteins and blood cells. | 1994 | 31 |
| 15 | 1989 | 28 | |
| 16 | 1996 | 27 | |
| 17 | 1998 | 26 | |
| 18 | 1989 | 26 | |
| 19 | 1997 | 16 | |
| 20 | 1989 | 16 |
About J.M. Scherrmann
J.M. Scherrmann is a scholar working on Molecular Biology, Emergency Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Nephrology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (6 papers), Poisoning and overdose treatments (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Forensic Toxicology and Drug Analysis (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Veterinary medicine and infectious diseases (5 papers), Receptor Mechanisms and Signaling (4 papers) and Paraquat toxicity studies and treatments (4 papers). The work is most often cited by research in Nephrology (168 citations), Neurology (174 citations), Pharmacology (126 citations), Oncology (357 citations) and Emergency Medicine (88 citations). J.M. Scherrmann has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include A. Sabouraud, C Bismuth, Anthony Régina, M Debray, Frédéric J. Baud, Myriam Rochdi, Nicolas Perrière, Mária A. Deli, Jamal Temsamani and Pierre Olivier Couraud. Their work appears in journals such as Toxicology and Applied Pharmacology, Toxicology, Clinical Chemistry, European Journal of Clinical Pharmacology and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.